CVE-2026-83193

Application takeover through undisclosed local flaw

Published Sep 15, 2026 · Updated Sep 15, 2026

Unspecified flaw in Oracle Siebel Life Sciences 17.0 through 26.7 allows local users to take over the application after user interaction. Oracle has not published the affected code path or the operation it performs incorrectly. Exploitation requires a low-privileged host account and interaction by another person, and successful exploitation compromises application data and operation.

CVSS severity7.3
High
EPSS probability0.16%
Next 30 days · Sep 16, 2026
Known exploitationUnconfirmed
Based on sourced intelligence
Hinoki checkNot available
Coverage for this vulnerability

See if you're affected

Explore vulnerability checks for your environment with Hinoki.

Book a demo

Summary

What happened

Unspecified flaw in Oracle Siebel Life Sciences 17.0 through 26.7 allows local users to take over the application after user interaction. Oracle has not published the affected code path or the operation it performs incorrectly. Exploitation requires a low-privileged host account and interaction by another person, and successful exploitation compromises application data and operation.

The record

CVE
CVE-2026-83193
Published
Sep 15, 2026
Updated
Sep 15, 2026
Vendor
Oracle Corporation
Product
Siebel Life Sciences
Classifications
Unavailable
Attack vector
local
Privileges
authenticated

Timeline

How it unfolded

  1. Sep 15, 2026CVE publishedPublication date reported by the CVE source.
  2. Sep 15, 2026Record updatedLatest update available in the CVE record.

Exploitability

Present is not the same as exploitable

Compare your product and version with the public record. A matching version still requires validation against your environment.

Is a vulnerable build present?

Compare these published version ranges with your installed build and any vendor patches.

  1. Affected versionversion=17.0 <=26.7

What conditions does exploitation require?

Attack vectorlocal
Required privilegesauthenticated

What is affected?

Oracle Corporation · Siebel Life Sciencesversion=17.0 <=26.7

Published CVSS scores

7.3Oracle CorporationCVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H

CVSS describes severity. EPSS estimates exploitation probability.

Attacks

What attackers are doing with it

Daily unique IPs observed by Shadowserver honeypots for known exploited vulnerabilities (KEVs). Missing observations do not establish an absence of attacks.

Daily unique IPsNo honeypot observations are available for this CVE in the selected window.

No observations available

Sep 10, 2026Sep 16, 2026
Latest reporting daySep 16, 2026
Latest daily unique IPsUnavailable
Prior 30-day averageUnavailable
SourceShadowserver honeypots (KEV)
Vectorlocal
Privilegesauthenticated
Known exploitationUnconfirmed
Public exploitUnconfirmed

Weakness, pattern, technique

No sourced classifications are available.

Public exploit references

No public exploit references are available in this record.

Labels summarize the accepted research assessment. They do not indicate a test against your environment.

Technologies

Your stack

See the directory against your own environment.

Your stack

Check the software in your environment

Book a demo to see how Hinoki identifies affected software and validates exploitability in your environment.

Book a demo